Tim Scott actually said...

To not take the original intent on the first biosimilar immediately as it's coming out seems to me to be a costly delay.

Keys are very important. My grandfather has encouraged me to know that.

It seems like your program, the medical translational technology program, has been successful...

We will take that up with the Chairwoman when we get back to D.C.